Voretigene Neparvovec
Midwest CEPAC
January 25, 2018
10am-4pm CT
Courtyard Marriott at Briarcliff
4000 North Mulberry Drive
Kansas City, MO
The Midwest CEPAC convened to deliberate on ICER's report on voretigene neparvovec (LuxturnaTM, Spark Therapeutics).
Key Dates
Associated Materials
06/16/2017 – 07/06/2017
07/10/2017
07/10/2017
07/10/2017 – 07/31/2017
08/07/2017
09/11/2017
09/11/2017
11/14/2017
11/14/2017
11/14/2017 – 12/13/2017
01/12/2018
01/12/2018
01/12/2018
01/25/2018
01/25/2018